Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CVS Health has announced expanded insurance coverage for two of Eli Lilly’s weight management drugs. Consequently, the move will significantly widen patient access. Millions of Americans rely on CVS for their pharmacy benefits, making this, therefore, a consequential shift. Starting…
The Food and Drug Administration approved a new pill called Foundayo on April 1, 2026. This move really changes how doctors treat weight issues today. The agency finished its review in just 50 days after getting the application. Consequently, this…
The FDA has officially approved Foundayo (orforglipron), completely transforming how we treat obesity and metabolic health. For years, patients relied heavily on injectable biologics like Wegovy or Zepbound. These medications worked exceptionally well, but needles, complex storage, and strict schedules…
Recently, The Lancet published a phase 3 clinical trial highlighting a promising new treatment for type 2 diabetes. Specifically, the ACHIEVE-3 study evaluated orforglipron, an innovative non-peptide GLP-1 receptor agonist, directly against oral semaglutide. The trial encompassed 1,698 adult patients…